Cost-Utility Analysis of Enzalutamide for Patients with Previously Treated Metastatic Castration-Resistant Prostate Cancer (MCRPC)
Abstract
Authors
C. Vicente V. Babashov F. Husein F. Saad S. Naidoo S. Holmstrom
C. Vicente V. Babashov F. Husein F. Saad S. Naidoo S. Holmstrom
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now